NDC 76282-206-01
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 76282-206
- Requested NDC
- 76282-206-01
- Package NDCs from labels
- 76282-206-01
- Manufacturer
- National Council for Prescription Drug Programs
- Effective date
- 2013-02-13
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| National Council for Prescription Drug Programs indexing - billing unit | National Council for Prescription Drug Programs | 2013-02-13 | Indexing - Billing Unit |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 76282-206-01 | EA - Each | 76282-206 | 4dd754cd-e019-4448-9edf-9fbd35fbc042 | 1 | 2013-02-13 |
| 76282-206-05 | EA - Each | 76282-206 | 01f73ae6-96d4-449d-bd21-fdd4337a126d | 1 | 2013-02-13 |
| 76282-206-10 | EA - Each | 76282-206 | 99df3585-5f4e-40e7-a4c6-ff8a9ccac747 | 1 | 2013-02-13 |
| 76282-206-90 | EA - Each | 76282-206 | 89d25f2f-1335-4ae6-87a4-ad4e22d722af | 1 | 2017-09-11 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Citalopram | CITALOPRAM | REMEDYREPACK INC. | c9809dfe-939e-4f9d-b6dd-f9808fd9f2b1 | 2026-07-21 | Boxed warning, Warnings, Adverse reactions | ANDA077534 |
| Citalopram | CITALOPRAM | REMEDYREPACK INC. | 25b0d184-2a4c-42b0-9a57-7a00fa3e0cd7 | 2026-07-15 | Boxed warning, Warnings, Adverse reactions | ANDA077534 |
| CITALOPRAM HYDROBROMIDE | CITALOPRAM | Aphena Pharma Solutions - Tennessee, LLC | 7307df53-d570-4e26-971d-e97522ccce7f | 2026-03-04 | Boxed warning, Warnings, Adverse reactions | ANDA077534 |
| Citalopram | CITALOPRAM | Northwind Health Company, LLC | f2b42bdc-47e0-19c5-e053-2a95a90a1828 | 2026-01-19 | Boxed warning, Warnings, Adverse reactions | ANDA077534 |
| Citalopram | CITALOPRAM | Northwind Health Company, LLC | f2b54f10-221f-5eed-e053-2995a90ab47f | 2026-01-01 | Boxed warning, Warnings, Adverse reactions | ANDA077534 |
| Citalopram | CITALOPRAM | Northwind Health Company, LLC | f77ef23b-3015-d074-e053-6394a90a11e1 | 2026-01-01 | Boxed warning, Warnings, Adverse reactions | ANDA077534 |
| Citalopram | CITALOPRAM | Cipla USA Inc. | 0580559a-783a-4a0a-8d81-ee30a29077c5 | 2024-08-01 | Boxed warning, Warnings, Adverse reactions | ANDA077534 |
| CITALOPRAM HYDROBROMIDE | CITALOPRAM | Exelan Pharmaceuticals Inc. | a8e8fde2-8392-4d5b-902b-e2b9dd55a02d | 2024-08-01 | Boxed warning, Warnings, Adverse reactions | ANDA077534 |
| Citalopram | CITALOPRAM | A-S Medication Solutions | c91684c7-fddb-4cf0-9711-b0484c8c7e8b | 2024-04-29 | Boxed warning, Warnings, Adverse reactions | ANDA077534 |
| Citalopram | CITALOPRAM | A-S Medication Solutions | 17af7a8d-ef57-4253-96ed-e457e0062eb5 | 2024-04-29 | Boxed warning, Warnings, Adverse reactions | ANDA077534 |
| Citalopram | CITALOPRAM | A-S Medication Solutions | 04ac5286-fc2e-4990-a574-ea21131ef731 | 2024-04-29 | Boxed warning, Warnings, Adverse reactions | ANDA077534 |
| Citalopram | CITALOPRAM | Aphena Pharma Solutions - Tennessee, LLC | 0867140e-a483-4bf7-8326-4a9730cc9d9d | 2020-04-22 | Boxed warning, Warnings, Adverse reactions | ANDA077534 |
| CITALOPRAM HYDROBROMIDE | CITALOPRAM | Aphena Pharma Solutions - Tennessee, LLC | d05f4e71-95f3-4f22-8b01-b21e5c19e0f2 | 2018-07-16 | Boxed warning, Warnings, Adverse reactions | ANDA077534 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.